MedPath
HSA Approval

LETROZOLE SANDOZ FILM COATED TABLETS 2.5MG

SIN14565P

LETROZOLE SANDOZ FILM COATED TABLETS 2.5MG

LETROZOLE SANDOZ FILM COATED TABLETS 2.5MG

June 27, 2014

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L02BG04

letrozole

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Novartis Pharma Stein AG

Novartis Farma S.P.A. (Primary and Secondary packager)

Active Ingredients

Letrozole

2.5mg

Letrozole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LETROZOLE SANDOZ FILM COATED TABLETS 2.5MG - HSA Approval | MedPath